1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Ying, J.
Ahn, J.-M.
Jacobsen, N.E.
Brown, M.F.
Hruby, V.J.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
H2 N
16.023
AMINO GROUP
non-polymer
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Biochemistry
BICHAW
0033
0006-2960
42
2825
2835
10.1021/bi026629r
12627948
NMR Solution Structure of the Glucagon Antagonist [desHis1, desPhe6, Glu9]Glucagon Amide in the Presence of Perdeuterated Dodecylphosphocholine Micelles
2003
10.2210/pdb1nau/pdb
pdb_00001nau
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
1
SINGLE WAVELENGTH
M
1
1.0
3213.495
Glucagon
DEL(H53), DEL(F58), D7E
1
syn
polymer
Glicentin-related polypeptide (GRPP)
no
yes
SQGTTSEYSKYLDSRRAQDFVQWLMNT(NH2)
SQGTTSEYSKYLDSRRAQDFVQWLMNTX
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
database_2
pdbx_nmr_software
pdbx_struct_assembly
pdbx_struct_oper_list
struct_conn
struct_ref_seq_dif
struct_site
repository
Initial release
Version format compliance
Version format compliance
Data collection
Database references
Derived calculations
1
0
2003-03-18
1
1
2008-04-28
1
2
2011-07-13
1
3
2021-10-27
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_nmr_software.name
_struct_conn.pdbx_leaving_atom_flag
_struct_ref_seq_dif.details
_struct_site.pdbx_auth_asym_id
_struct_site.pdbx_auth_comp_id
_struct_site.pdbx_auth_seq_id
RCSB
Y
RCSB
2002-11-28
REL
REL
This sequence was chemically synthesized. It was obtained by modifying the sequence of glucagon, which occurs naturally in Homo sapiens (human).
sample
This structure was determined using standard 2D homonuclear techniques.
15 structures with the lowest restraint energy
50
16
DQF-COSY
2D TOCSY
2D NOESY
50 mM sodium phosphate; 1mM sodium azide
6.0
ambient
310
K
The structures are based on a total of 486 restraints, 475 are NOE-derived distance restraints, 11 dihedral angle restraints
distance geometry, restrained molecular dynamics
1
minimized average structure
7mM [desHis1, desPhe6, Glu9]Glucagon Amide; 50 mM sodium phosphate buffer; 283 mM dodecylphosphocholine-d38 micelles; 1 mM sodium azide; 90% H2O, 10% D2O
90% H2O/10% D2O
Bruker
collection
UXNMR
Accelrys
processing
Felix
2000
Accelrys
data analysis
Felix
2000
Accelrys
structure solution
DGII
within InsightII 2000
Accelrys
refinement
Discover
within InsightII 2000
500
Bruker
AMX
SER
1
n
1
SER
1
A
GLN
2
n
2
GLN
2
A
GLY
3
n
3
GLY
3
A
THR
4
n
4
THR
4
A
THR
5
n
5
THR
5
A
SER
6
n
6
SER
6
A
GLU
7
n
7
GLU
7
A
TYR
8
n
8
TYR
8
A
SER
9
n
9
SER
9
A
LYS
10
n
10
LYS
10
A
TYR
11
n
11
TYR
11
A
LEU
12
n
12
LEU
12
A
ASP
13
n
13
ASP
13
A
SER
14
n
14
SER
14
A
ARG
15
n
15
ARG
15
A
ARG
16
n
16
ARG
16
A
ALA
17
n
17
ALA
17
A
GLN
18
n
18
GLN
18
A
ASP
19
n
19
ASP
19
A
PHE
20
n
20
PHE
20
A
VAL
21
n
21
VAL
21
A
GLN
22
n
22
GLN
22
A
TRP
23
n
23
TRP
23
A
LEU
24
n
24
LEU
24
A
MET
25
n
25
MET
25
A
ASN
26
n
26
ASN
26
A
THR
27
n
27
THR
27
A
NH2
28
n
28
NH2
28
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
identity operation
0.0000000000
0.0000000000
0.0000000000
1
A
TYR
11
0.087
SIDE CHAIN
2
A
TYR
8
0.077
SIDE CHAIN
12
A
TYR
11
0.062
SIDE CHAIN
16
A
TYR
11
0.072
SIDE CHAIN
1
A
THR
5
41.92
-109.24
1
A
ASP
13
-82.79
-115.87
1
A
SER
14
-96.68
-114.11
2
A
GLN
2
-164.39
-46.58
2
A
THR
4
-149.91
-149.29
2
A
GLU
7
-90.37
58.48
2
A
TYR
8
-160.07
-69.18
2
A
ARG
15
-171.73
-49.83
3
A
ARG
15
-179.47
-55.73
4
A
TYR
11
-86.69
47.51
4
A
LEU
12
-134.61
-47.00
4
A
ASP
13
-37.88
-95.53
4
A
SER
14
-140.73
-114.93
5
A
TYR
11
-85.07
42.08
5
A
ASP
13
-73.66
-138.87
5
A
SER
14
-94.30
-101.58
6
A
THR
4
-142.38
17.50
6
A
THR
5
-147.14
-61.37
6
A
TYR
8
-164.99
-60.11
6
A
LEU
12
-151.22
67.28
6
A
ASP
13
-140.34
-130.23
7
A
THR
4
-162.33
36.77
7
A
THR
5
-143.52
-70.23
7
A
ASP
13
-74.93
-123.06
7
A
SER
14
-120.51
-86.54
8
A
THR
4
-100.63
-95.48
8
A
GLU
7
-89.58
-73.27
8
A
ASP
13
-78.45
-118.83
8
A
SER
14
-100.73
-108.09
9
A
ASP
13
-70.98
-137.80
9
A
SER
14
-89.99
-106.72
10
A
THR
4
-156.28
-58.95
10
A
LEU
12
-138.44
-44.80
10
A
ASP
13
-40.34
-92.43
10
A
SER
14
-150.09
-103.96
11
A
THR
5
49.68
-96.31
11
A
TYR
11
-91.03
53.44
11
A
ASP
13
-78.22
-124.20
11
A
SER
14
-94.28
-110.82
12
A
THR
5
45.76
-97.21
12
A
LEU
12
-141.64
-43.98
12
A
ASP
13
-39.57
-95.65
12
A
SER
14
-150.40
-93.87
13
A
THR
4
-157.67
-62.10
13
A
ASP
13
-77.03
-126.09
13
A
SER
14
-104.62
-114.45
14
A
GLN
2
43.92
-117.32
14
A
GLU
7
-90.12
-61.48
14
A
SER
14
-130.29
-99.87
14
A
ARG
15
-156.70
29.32
15
A
THR
4
-107.41
-109.64
15
A
THR
5
-143.91
-61.34
15
A
ARG
15
-179.07
-54.48
16
A
TYR
11
-86.75
49.81
16
A
LEU
12
-141.13
-40.24
16
A
ASP
13
-40.95
-91.44
16
A
SER
14
-143.73
-115.27
minimized average
NMR Solution Structure of the Glucagon Antagonist [desHis1, desPhe6, Glu9]Glucagon Amide in the Presence of Perdeuterated Dodecylphosphocholine Micelles
1
N
N
A
THR
5
A
THR
5
HELX_P
A
TYR
11
A
TYR
11
1
1
7
A
SER
14
A
SER
14
HELX_P
A
THR
27
A
THR
27
1
2
14
covale
1.335
both
A
THR
27
A
C
THR
27
1_555
A
NH2
28
A
N
NH2
28
1_555
HORMONE/GROWTH FACTOR
HELIX, TURN, HORMONE-GROWTH FACTOR COMPLEX
GLUC_HUMAN
UNP
1
53
P01275
HSQGTFTSDYSKYLDSRRAQDFVQWLMNT
53
81
1NAU
1
27
P01275
A
1
1
27
1
HIS
deletion
1NAU
A
P01275
UNP
53
1
PHE
deletion
1NAU
A
P01275
UNP
58
1
ASP
engineered mutation
GLU
7
1NAU
A
P01275
UNP
61
7
BINDING SITE FOR RESIDUE NH2 A 28
A
NH2
28
Software
2
A
ASN
26
A
ASN
26
2
1_555
A
THR
27
A
THR
27
2
1_555